Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2017, Article ID 3918681, 6 pages
https://doi.org/10.1155/2017/3918681
Research Article

Urinary Microvesicle-Bound Uromodulin: A Potential Molecular Biomarker in Diabetic Kidney Disease

1The Second Hospital of Shandong University, 247 Beiyuan Street, Ji’nan, Shandong 250033, China
2Department of Biochemistry, School of Medicine of Shandong University, Shandong, China

Correspondence should be addressed to Ai-li Sun; moc.361@nsyllia

Received 15 October 2016; Revised 27 November 2016; Accepted 4 December 2016; Published 15 January 2017

Academic Editor: Carlos Martinez Salgado

Copyright © 2017 Neng-jun Lou et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. T. Reutens, “Epidemiology of diabetic kidney disease,” Medical Clinics of North America, vol. 97, no. 1, pp. 1–18, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. C. W. Park, “Diabetic kidney disease: from epidemiology to clinical perspectives,” Diabetes and Metabolism Journal, vol. 38, no. 4, pp. 252–260, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. G. Remuzzi, A. Schieppati, and P. Ruggenenti, “Nephropathy in patients with type 2 diabetes,” New England Journal of Medicine, vol. 346, no. 15, pp. 1145–1151, 2002. View at Publisher · View at Google Scholar · View at Scopus
  4. P. Fioretto and M. Mauer, “Histopathology of diabetic nephropathy,” Seminars in Nephrology, vol. 27, no. 2, pp. 195–207, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. W.-H. Lau, W.-S. Leong, Z. Ismail, and L.-H. Gam, “Qualification and application of an ELISA for the determination of tamm horsfall protein (THP) in human urine and its use for screening of kidney stone disease,” International Journal of Biological Sciences, vol. 4, no. 4, pp. 215–222, 2008. View at Google Scholar · View at Scopus
  6. I. Sejdiu and O. Torffvit, “Decreased urinary concentration of Tamm-Horsfall protein is associated with development of renal failure and cardiovascular death within 20 years in type 1 but not in type 2 diabetic patients,” Scandinavian Journal of Urology and Nephrology, vol. 42, no. 2, pp. 168–174, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. Y. Akioka, H. Chikamoto, S. Horita et al., “Screening of vesicoureteral reflux in pediatric patients with kidney transplantation showing non-specific interstitial fibrosis and tubular atrophy with interstitial Tamm-Horsfall protein deposits in protocol allograft biopsy,” Clinical Transplantation, vol. 23, no. 20, pp. 2–5, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Möllsten and O. Torffvit, “Tamm-Horsfall protein gene is associated with distal tubular dysfunction in patients with type 1 diabetes,” Scandinavian Journal of Urology and Nephrology, vol. 44, no. 6, pp. 438–444, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. M. E. De Broe, F. Roels, E. J. Nouwen, L. Claeys, and R. J. Wieme, “Liver plasma membrane: the source of high molecular weight alkaline phosphatase in human serum,” Hepatology, vol. 5, no. 1, pp. 118–128, 1985. View at Publisher · View at Google Scholar · View at Scopus
  10. X. P. Lin, N. Almqvist, and E. Telemo, “Human small intestinal epithelial cells constitutively express the key elements for antigen processing and the production of exosomes,” Blood Cells, Molecules, and Diseases, vol. 35, no. 2, pp. 122–128, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Fauré, G. Lachenal, M. Court et al., “Exosomes are released by cultured cortical neurones,” Molecular and Cellular Neuroscience, vol. 31, no. 4, pp. 642–648, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. Y. Wang, L.-M. Chen, and M.-L. Liu, “Microvesicles and diabetic complications—novel mediators, potential biomarkers and therapeutic targets,” Acta Pharmacologica Sinica, vol. 35, no. 4, pp. 433–443, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. F. Raimondo, S. Corbetta, L. Morosi et al., “Urinary exosomes and diabetic nephropathy: a proteomic approach,” Molecular BioSystems, vol. 9, no. 6, pp. 1139–1146, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. I. Zubiri, M. Posada-Ayala, A. Benito-Martin et al., “Kidney tissue proteomics reveals regucalcin downregulation in response to diabetic nephropathy with reflection in urinary exosomes,” Translational Research, vol. 166, no. 5, pp. 474.e4–484.e4, 2015. View at Publisher · View at Google Scholar · View at Scopus
  15. L. Musante, D. E. Tataruch, and H. Holthofer, “Use and isolation of urinary exosomes as biomarkers for diabetic nephropathy,” Frontiers in Endocrinology, vol. 5, article 149, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. A.-L. Sun, J.-T. Deng, G.-J. Guan et al., “Dipeptidyl peptidase-IV is a potential molecular biomarker in diabetic kidney disease,” Diabetes and Vascular Disease Research, vol. 9, no. 4, pp. 301–308, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Kalani, A. Mohan, M. M. Godbole et al., “Wilm's tumor-1 protein levels in urinary exosomes from diabetic patients with or without proteinuria,” PLoS ONE, vol. 8, no. 3, Article ID e60177, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. H. Zhou, H. Kajiyama, T. Tsuji et al., “Urinary exosomal Wilms' tumor-1 as a potential biomarker for podocyte injury,” American Journal of Physiology—Renal Physiology, vol. 305, no. 4, pp. F553–F559, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. J. T. Deng, M. F. Hoylaerts, E. J. Nouwen, M. E. De Broe, and V. O. Van Hoof, “Purification of circulating liver plasma membrane fragments using a monoclonal antileucine aminopeptidase antibody,” Hepatology, vol. 23, no. 3, pp. 445–454, 1996. View at Publisher · View at Google Scholar · View at Scopus
  20. J. Ti Deng and P. G. Parsons, “Solid phase immunoassay for high molecular weight alkaline phosphatase in human sera using a specific monoclonal antibody,” Clinica Chimica Acta, vol. 176, no. 3, pp. 291–301, 1988. View at Publisher · View at Google Scholar · View at Scopus
  21. A. Cheruvanky, H. Zhou, T. Pisitkun et al., “Rapid isolation of urinary exosomal biomarkers using a nanomembrane ultrafiltration concentrator,” American Journal of Physiology—Renal Physiology, vol. 292, no. 5, pp. F1657–F1661, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. V. Thongboonkerd, “Study of diabetic nephropathy in the proteomic era,” Diabetes and the Kidney, vol. 170, pp. 172–183, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. T. Pisitkun, R.-F. Shen, and M. A. Knepper, “Identification and proteomic profiling of exosomes in human urine,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 36, pp. 13368–13373, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. J. Conde-Vancells, E. Rodriguez-Suarez, E. Gonzalez et al., “Candidate biomarkers in exosome-like vesicles purified from rat and mouse urine samples,” Proteomics—Clinical Applications, vol. 4, no. 4, pp. 416–425, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. S. P. Ardoin, J. C. Shanahan, and D. S. Pisetsky, “The role of microparticles in inflammation and thrombosis,” Scandinavian Journal of Immunology, vol. 66, no. 2-3, pp. 159–165, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. Y. Qu, E. Du, Y. Zhang, S. Li, R. Han, and M. Qiu, “Changes in the expression of bone morphogenetic protein 7 and tamm—horsfall protein in the early stages of diabetic nephropathy,” Nephro-Urology Monthly, vol. 4, no. 2, pp. 466–469, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. C.-D. Agardh, U. Stenram, O. Torffvit, and E. Agardh, “Effects of inhibition of glycation and oxidative stress on the development of diabetic nephropathy in rats,” Journal of Diabetes and its Complications, vol. 16, no. 6, pp. 395–400, 2002. View at Publisher · View at Google Scholar · View at Scopus
  28. N. M. Bhensdadia, K. J. Hunt, M. F. Lopes-Virella et al., “Urine haptoglobin levels predict early renal functional decline in patients with type 2 diabetes,” Kidney International, vol. 83, no. 6, pp. 1136–1143, 2013. View at Publisher · View at Google Scholar · View at Scopus
  29. O. Torffvit, C.-D. Agardh, and T. Thulin, “A study of Tamm-Horsfall protein excretion in hypertensive patients and type 1 diabetic patients,” Scandinavian Journal of Urology and Nephrology, vol. 33, no. 3, pp. 187–191, 1999. View at Publisher · View at Google Scholar · View at Scopus
  30. A. Matheson, M. D. P. Willcox, J. Flanagan, and B. J. Walsh, “Urinary biomarkers involved in type 2 diabetes: a review,” Diabetes/Metabolism Research and Reviews, vol. 26, no. 3, pp. 150–171, 2010. View at Publisher · View at Google Scholar · View at Scopus